Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Completed 4Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3FED 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 3Thoracic 1

Conditions

Prostatic Neoplasms 2Smoking Cessation 1Prostate Cancer Prevention 1Lung Neoplasms 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Interventional × sulforaphane × Clear all
NCT03232138 2024-12-17

Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers

University of Pittsburgh

Phase 2 Completed
43 enrolled 19 charts
Thoracic

Lung Neoplasms, Smoking Cessation

NCT04046653 2020-11-18

ADaPT

Quadram Institute Bioscience

Phase NA Completed
40 enrolled
Genitourinary

Prostatic Neoplasms

NCT01265953 2019-05-01

PBroC

Portland VA Medical Center

Phase NA Completed
98 enrolled 10 charts
Genitourinary

Prostate Cancer Prevention

NCT01228084 2017-04-28

Sulforaphane in Treating Patients With Recurrent Prostate Cancer

OHSU Knight Cancer Institute

Phase 2 Completed
20 enrolled 11 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡